In a bid to advance alternative approaches to animal models and develop better and more predictive scientific tools, Roche Holding AG has launched the Institute of Human Biology (IHB) focusing on research in the field of human model systems such as organoids.
The IHB is bringing together researchers in academia and the pharmaceutical industry to create reliable predictive models that better emulate the human body and deploying them directly into drug discovery and development. The institute's head, Matthias Lütolf, said the project "combines the best of both worlds — exploratory research as in academia but with a clear translational goal ..
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?